Quirky Novartis Bet Pushes Biopharma M&A Beyond $100 Billion Novartis is buying Avidity Biosciences in a $12 billion deal By Michelle F Davis · Bloomberg Novartis is buying Avidity Biosciences in a $12 billion deal